View : 15 Download: 0

Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis

Title
Sirolimus- versus paclitaxel-eluting stent implantation for unprotected left main coronary artery stenosis
Authors
Sang H.L.Ko Y.-G.Jang Y.Hyuck M.K.Lee S.-H.Yoon J.H.Si H.P.Byung O.K.Dong W.J.Joo Y.Y.Ryu S.-K.
Ewha Authors
박시훈
SCOPUS Author ID
박시훈scopus
Issue Date
2005
Journal Title
Cardiology
ISSN
0008-6312JCR Link
Citation
vol. 104, no. 4, pp. 181 - 185
Indexed
SCI; SCIE; SCOPUS WOS scopus
Abstract
We performed this study in order to compare the immediate and mid-term outcomes of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) in lesions of the unprotected left main coronary artery (LMCA). We assessed 54 patients from 5 centers who had undergone unprotected LMCA stenting (35 SES and 19 PES). The procedural success rates were 100 and 95%, respectively, in the SES and PES patients (p = 0.19). At the 6-month clinical follow-up, the event-free probability was 100% in the SES group, and 88% in the PES group (p = 0.07). At the 6-month angiographic follow-up (n = 24), the SES group exhibited a slightly lower late loss than did the PES group (0.24 ± 0.44 vs. 0.65 ± 0.60 mm, p = 0.09), and the restenosis rates were 8 and 9% (p = 0.94) in the SES and PES patients, respectively. In conclusion, both groups exhibited excellent in-hospital and 6-month outcomes with no significant differences between them. Copyright © 2005 S. Karger AG.
DOI
10.1159/000088106
Appears in Collections:
의학전문대학원 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE